Search research articles
Contact Us
Filters
Showing results (111-120 of 149) with videos related to
Page
of 15
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
August 27, 2024
KRT18 as a Novel Biomarker of Urothelial Papilloma while Evaluating Low-Grade Papillary Urothelial Neoplasms: Bi-Center Analysis
Minsun Jung, Bohyun Kim, Jae Seok Lee, et al.
Cancer Research and Treatment
|
August 8, 2025
DNA damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status
So Hyeon Kim, Yoonjung Park, Ahrum Min, et al.
Nature Communications
|
May 6, 2017
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Woosung Chung, Hye Hyeon Eum, Hae-Ock Lee, et al.
Cancers
|
April 25, 2020
Moesin (<i>MSN</i>) as a Novel Proteome-Based Diagnostic Marker for Early Detection of Invasive Bladder Urothelial Carcinoma in Liquid-Based Cytology
Jeong Hwan Park, Cheol Lee, Dohyun Han, et al.
International Journal of Cancer
|
September 2, 2022
Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer
Bohyun Kim, Minsun Jung, Kyung Chul Moon, et al.
Science Advances
|
February 22, 2020
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms
Mark Borris D Aldonza, Jayoung Ku, Ji-Young Hong, et al.
Molecular & Cellular Proteomics : MCP
|
June 29, 2018
Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology
Hyebin Lee, Kwangsoo Kim, Jongmin Woo, et al.
Journal of Translational Medicine
|
January 7, 2021
Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy
Seongyeong Kim, Dongjin Shin, Ahrum Min, et al.
Breast Cancer Research and Treatment
|
June 23, 2016
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer
Koung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
American Journal of Clinical Pathology
|
November 13, 2014
HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer
Hee Jin Lee, An Na Seo, Eun Joo Kim, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 149) with videos related to
Sort By:
Page
of 15
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
August 27, 2024
KRT18 as a Novel Biomarker of Urothelial Papilloma while Evaluating Low-Grade Papillary Urothelial Neoplasms: Bi-Center Analysis
Minsun Jung, Bohyun Kim, Jae Seok Lee, et al.
Cancer Research and Treatment
|
August 8, 2025
DNA damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status
So Hyeon Kim, Yoonjung Park, Ahrum Min, et al.
Nature Communications
|
May 6, 2017
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Woosung Chung, Hye Hyeon Eum, Hae-Ock Lee, et al.
Cancers
|
April 25, 2020
Moesin (<i>MSN</i>) as a Novel Proteome-Based Diagnostic Marker for Early Detection of Invasive Bladder Urothelial Carcinoma in Liquid-Based Cytology
Jeong Hwan Park, Cheol Lee, Dohyun Han, et al.
International Journal of Cancer
|
September 2, 2022
Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer
Bohyun Kim, Minsun Jung, Kyung Chul Moon, et al.
Science Advances
|
February 22, 2020
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms
Mark Borris D Aldonza, Jayoung Ku, Ji-Young Hong, et al.
Molecular & Cellular Proteomics : MCP
|
June 29, 2018
Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology
Hyebin Lee, Kwangsoo Kim, Jongmin Woo, et al.
Journal of Translational Medicine
|
January 7, 2021
Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy
Seongyeong Kim, Dongjin Shin, Ahrum Min, et al.
Breast Cancer Research and Treatment
|
June 23, 2016
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer
Koung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
American Journal of Clinical Pathology
|
November 13, 2014
HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer
Hee Jin Lee, An Na Seo, Eun Joo Kim, et al.
Page
of 15